PROCEPT BioRobotics Corporation Interest Expense Nonoperating
PROCEPT BioRobotics Corporation (PRCT) reported Interest Expense Nonoperating of $842.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement
us-gaap:InterestExpenseNonoperating · last filed 2026-08-05
- PROCEPT BioRobotics Corporation interest expense nonoperating for the quarter ending 2026-06-30 was $842.00K, a 5.92% decline year-over-year.
- PROCEPT BioRobotics Corporation interest expense nonoperating for the quarter ending 2026-03-31 was $818.00K, a 6.73% decline year-over-year.
- PROCEPT BioRobotics Corporation interest expense nonoperating for the quarter ending 2025-12-31 was $894.00K, a 7.74% decline year-over-year.
- PROCEPT BioRobotics Corporation interest expense nonoperating for the quarter ending 2025-09-30 was $919.00K, a 19.39% decline year-over-year.
- PROCEPT BioRobotics Corporation interest expense nonoperating for fiscal 2025 was $3.59M, a 14.29% decline from fiscal 2024.
- PROCEPT BioRobotics Corporation interest expense nonoperating for fiscal 2024 was $4.18M, a 4.73% increase from fiscal 2023.
- PROCEPT BioRobotics Corporation interest expense nonoperating for fiscal 2023 was $4.00M, a 22.92% decline from fiscal 2022.
- PROCEPT BioRobotics Corporation interest expense nonoperating for fiscal 2022 was $5.18M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $842.00K 10-Q · filed 2026-08-05 | $1.66M 10-Q · filed 2026-08-05 | $2.55M derived: sum of 3 quarters · filed 2026-08-05 | $3.47M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $818.00K 10-Q · filed 2026-04-30 | $1.71M derived: sum of 2 quarters · filed 2026-04-30 | $2.63M derived: sum of 3 quarters · filed 2026-04-30 | $3.53M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $894.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.81M derived: sum of 2 quarters · filed 2026-02-26 | $2.71M derived: sum of 3 quarters · filed 2026-08-05 | $3.59M 10-K · filed 2026-02-26 |
| 2025-09-30 | $919.00K 10-Q · filed 2025-11-05 | $1.81M derived: sum of 2 quarters · filed 2026-08-05 | $2.69M 10-Q · filed 2025-11-05 | $3.66M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $895.00K 10-Q · filed 2026-08-05 | $1.77M 10-Q · filed 2026-08-05 | $2.74M derived: sum of 3 quarters · filed 2026-08-05 | $3.88M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $877.00K 10-Q · filed 2026-04-30 | $1.85M derived: sum of 2 quarters · filed 2026-04-30 | $2.99M derived: sum of 3 quarters · filed 2026-04-30 | $4.02M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $969.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.11M derived: sum of 2 quarters · filed 2026-02-26 | $3.14M derived: sum of 3 quarters · filed 2026-02-26 | $4.18M 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.14M 10-Q · filed 2025-11-05 | $2.17M derived: sum of 2 quarters · filed 2025-11-05 | $3.21M 10-Q · filed 2025-11-05 | $4.34M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $1.03M 10-Q · filed 2025-08-07 | $2.08M 10-Q · filed 2025-08-07 | $3.20M derived: sum of 3 quarters · filed 2026-02-26 | $4.22M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $1.04M 10-Q · filed 2025-05-02 | $2.17M derived: sum of 2 quarters · filed 2026-02-26 | $3.19M derived: sum of 3 quarters · filed 2026-02-26 | $4.15M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.14M derived: sum of 2 quarters · filed 2026-02-26 | $3.11M derived: sum of 3 quarters · filed 2026-02-26 | $4.00M 10-K · filed 2026-02-26 |
| 2023-09-30 | $1.02M 10-Q · filed 2024-10-28 | $1.98M derived: sum of 2 quarters · filed 2024-10-28 | $2.87M 10-Q · filed 2024-10-28 | |
| 2023-06-30 | $965.00K 10-Q · filed 2024-08-02 | $1.85M 10-Q · filed 2024-08-02 | ||
| 2022-12-31 | $5.18M 10-K · filed 2025-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |